BIO-key Reports Q3 2026 Earnings Driven by High-Margin Software License Growth

BIO-key (BKYI) reported strong third-quarter 2026 financial results, highlighted by a strategic shift toward high-margin software licenses. Software license revenue now accounts for 86% of total revenue, driving gross profit margins up to 90%, compared to 77% in the same period last year. This transition is helping the company reduce operating losses and move toward a goal of profitability. The company is seeing significant international momentum, specifically adding eight new customers in the Middle East over the past seven months due to strict security mandates. Additionally, BIO-key is positioning its Identity-Bound Biometrics technology to address emerging risks associated with artificial intelligence by ensuring human authorization for sensitive AI-driven actions.

7 articles from 3 sources · updated

Coverage